Course Overview
Repurposed Medications in Oncology: A Study Guide for Doctors (Module 1, Course 2 – Ivermectin) explores the growing body of research surrounding ivermectin as an anti-cancer therapy. Originally developed as an antiparasitic medication, ivermectin has demonstrated promising potential in oncology by influencing multiple biological pathways, including apoptosis induction, inhibition of angiogenesis, and immune system modulation.
This study guide provides a thorough analysis of the evidence supporting ivermectin’s role in cancer treatment, offering insights into its pharmacokinetics, drug interactions, and its synergy with chemotherapy and immunotherapy.
Who is This Course For?
- Oncologists and Cancer Researchers
- Integrative and Functional Medicine Doctors
- Medical Students and Healthcare Practitioners
- Pharmacists and Clinical Scientists
What You Will Learn
- The cellular and molecular mechanisms behind ivermectin’s anti-cancer activity
- How ivermectin interacts with cancer cell metabolism and multi-drug resistance mechanisms
- Current preclinical and clinical trial data supporting its role in oncology
- The impact of ivermectin on tumor microenvironments and immunotherapy synergy
- Best practices for dosing, toxicity monitoring, and patient selection
Course Structure & Content
- Introduction to Ivermectin – Discovery, FDA Approvals, and Repurposing in Oncology
- Mechanisms Behind Ivermectin’s Anti-Cancer Effects
- The FDA Approval Process and Off-Label Use in Cancer Care
- Preclinical and Clinical Research – Key Studies and Findings
- Pharmacokinetics, Drug Interactions, and Metabolism Considerations
- Hallmarks of Cancer and Aging – How Ivermectin Influences Tumor Progression
- Dosing, Toxicity, and Laboratory Monitoring
- Conclusion and Next Steps in Research
- Self-Guided Medical Quiz
- FAQ – Addressing Common Questions from Doctors
Reviews
There are no reviews yet.